VOYA Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$181M Buy
6,450,240
+1,183,538
+22% +$31.5M 0.19% 126
2025
Q4
$131M Sell
5,266,702
-15,251
-0.3% -$385K 0.13% 173
2025
Q3
$135M Buy
5,281,953
+688,225
+15% +$17M 0.13% 166
2025
Q2
$111M Buy
4,593,728
+2,916,023
+174% +$68M 0.11% 199
2025
Q1
$42.5M Buy
1,677,705
+80,646
+5% +$2.11M 0.05% 343
2024
Q4
$42.4M Sell
1,597,059
-196,212
-11% -$5.32M 0.04% 351
2024
Q3
$51.9M Sell
1,793,271
-617,817
-26% -$18M 0.05% 328
2024
Q2
$67.5M Sell
2,411,088
-125,184
-5% -$3.45M 0.07% 270
2024
Q1
$70.4M Sell
2,536,272
-303,210
-11% -$8.41M 0.07% 271
2023
Q4
$81.7M Buy
2,839,482
+6,173
+0.2% +$187K 0.08% 255
2023
Q3
$94M Buy
2,833,309
+46,933
+2% +$1.66M 0.1% 227
2023
Q2
$102M Sell
2,786,376
-222,506
-7% -$8.66M 0.11% 221
2023
Q1
$123M Sell
3,008,882
-163,349
-5% -$7.06M 0.13% 201
2022
Q4
$163M Buy
3,172,231
+99,389
+3% +$4.77M 0.19% 146
2022
Q3
$134M Buy
3,072,842
+64,275
+2% +$3.12M 0.16% 150
2022
Q2
$158M Sell
3,008,567
-55,942
-2% -$2.85M 0.4% 57
2022
Q1
$159M Sell
3,064,509
-15,814
-0.5% -$821K 0.33% 66
2021
Q4
$182M Buy
3,080,323
+364,736
+13% +$18.1M 0.35% 63
2021
Q3
$117M Sell
2,715,587
-84,271
-3% -$3.73M 0.23% 99
2021
Q2
$110M Sell
2,799,858
-38,410
-1% -$1.49M 0.21% 108
2021
Q1
$103M Sell
2,838,268
-65,533
-2% -$2.33M 0.21% 113
2020
Q4
$107M Sell
2,903,801
-481,530
-14% -$17.7M 0.22% 113
2020
Q3
$118M Sell
3,385,331
-147,261
-4% -$5.16M 0.26% 95
2020
Q2
$110M Sell
3,532,592
-435,615
-11% -$14.8M 0.25% 82
2020
Q1
$123M Sell
3,968,207
-18,044
-0.5% -$615K 0.33% 65
2019
Q4
$148M Buy
3,986,251
+238,644
+6% +$8.5M 0.31% 76
2019
Q3
$128M Sell
3,747,607
-3,179,418
-46% -$116M 0.28% 78
2019
Q2
$285M Buy
6,927,025
+530,514
+8% +$21.1M 0.61% 34
2019
Q1
$258M Sell
6,396,511
-1,141,708
-15% -$45.7M 0.58% 38
2018
Q4
$312M Sell
7,538,219
-1,688,338
-18% -$70.1M 0.77% 18
2018
Q3
$386M Buy
9,226,557
+1,034
+0% +$39.8K 0.79% 16
2018
Q2
$318M Sell
9,225,523
-123,645
-1% -$4.23M 0.68% 18
2018
Q1
$315M Buy
9,349,168
+51,949
+0.6% +$1.79M 0.67% 24
2017
Q4
$319M Buy
9,297,219
+122,537
+1% +$4.18M 0.66% 26
2017
Q3
$311M Sell
9,174,682
-592,893
-6% -$19.1M 0.67% 21
2017
Q2
$311M Buy
9,767,575
+250,410
+3% +$7.9M 0.7% 21
2017
Q1
$309M Buy
9,517,165
+819,349
+9% +$25.8M 0.71% 20
2016
Q4
$268M Buy
8,697,816
+2,846,703
+49% +$86.9M 0.64% 28
2016
Q3
$188K Buy
5,851,113
+2,551,948
+77% +$85.3M 0.36% 51
2016
Q2
$110M Sell
3,299,165
-248,226
-7% -$7.92M 0.27% 102
2016
Q1
$99.8M Sell
3,547,391
-6,896,464
-66% -$197M 0.25% 108
2015
Q4
$320M Sell
10,443,855
-1,932,022
-16% -$60.8M 0.78% 20
2015
Q3
$369M Buy
12,375,877
+1,909,251
+18% +$61.2M 0.93% 16
2015
Q2
$333M Sell
10,466,626
-2,517,235
-19% -$82M 0.76% 20
2015
Q1
$429M Buy
12,983,861
+1,420,979
+12% +$45.2M 0.95% 11
2014
Q4
$342M Sell
11,562,882
-168,487
-1% -$4.83M 0.76% 20
2014
Q3
$329M Buy
11,731,369
+616,298
+6% +$17.3M 0.75% 17
2014
Q2
$313M Sell
11,115,071
-762,286
-6% -$21.7M 0.72% 18
2014
Q1
$362M Buy
11,877,357
+3,756,546
+46% +$112M 0.84% 16
2013
Q4
$236M Buy
8,120,811
+3,156,719
+64% +$91.9M 0.55% 52
2013
Q3
$135M Sell
4,964,092
-423,720
-8% -$11.5M 0.34% 82
2013
Q2
$143M Buy
+5,387,812
New +$149M 0.4% 66

Other funds holding PFE

VOYA Investment Management's PFE Position: Q1 2026 in Review

VOYA Investment Management increased its Pfizer (PFE) stake by 22% in Q1 2026, buying an estimated $31.5M and bringing the position to 6,450,240 shares worth $181M. The position accounts for 0.19% of the portfolio, ranked #126.

VOYA Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $429M in Q1 2015. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • VOYA Investment Management held 6,450,240 shares of Pfizer worth $181M as of Q1 2026.
  • VOYA Investment Management bought 1,183,538 Pfizer shares in Q1 2026, an estimated $31.5M.
  • Pfizer made up 0.19% of VOYA Investment Management's portfolio in Q1 2026, its #126 holding.
  • VOYA Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Pfizer position peaked at $429M in Q1 2015.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.